Key result
A 60-year-old male with aneurysmal subarachnoid hemorrhage developed stress cardiomyopathy mimicking STEMI, highlighting the danger of inappropriate antithrombotic therapy in such misdiagnoses.
Why the study?
Frank ST-elevation and myocardial dysfunction mimicking acute coronary syndrome rarely occur in acute subarachnoid hemorrhage, presenting diagnostic challenges that can lead to inappropriate antithrombotic therapies.
Case Report (n=1)
No
Neurologic myocardial stunning in subarachnoid hemorrhage can mimic STEMI, highlighting the importance of careful clinical history to avoid catastrophic consequences from inappropriate antithrombotic therapy.
Stress cardiomyopathy can mimic STEMI in SAH; leaves open refined diagnostics to avert antithrombotic harm in neurocritical care.
Cardiac abnormalities are frequently reported in acute subarachnoid hemorrhage (SAH) patients. However, frank ST-elevation and myocardial dysfunction mimicking acute coronary syndrome is a rare occurrence. Systemic and local catecholamine release mediate myocardial injury and may explain raised troponin levels, concordant regional wall motion abnormalities and systolic dysfunction. These findings can pose a significant problem in the acute setting where "time-is-muscle" paradigm can rush clinicians towards a "rule-in" diagnosis of acute myocardial infarction. We present the case of a 60-year-old male who arrived at a regional emergency department with loss of consciousness, chest pain and headache. His ECG showed ST-elevation in precordial leads with corresponding region wall motion abnormalities and dynamically elevated troponin levels which supported a diagnosis of acute myocardial infarction. Percutaneous coronary intervention was attempted but found no hemodynamically significant lesions and the patient was managed conservatively with antithrombotic treatment. Further work-up for his headache led to the diagnosis of aneurysmal SAH and subsequent endovascular coiling. The patient was discharged with a good clinical outcome. We discuss the potential catastrophic consequences of interpreting neurologic myocardial stunning as STEMI. Use of potent antithrombotic therapies, like bridging thrombolysis, in this setting can lead to dismal consequences. Clinical history should still be carefully obtained in the acute setting in this era of sensitive biomarkers.
No takes yet. Share an insight, caveat, or question.
Enache et al. (2020) conducted a case report in Subarachnoid hemorrhage and stress cardiomyopathy (n=1). Endovascular coiling and conservative cardiac management was evaluated on Clinical recovery and correct diagnosis. A 60-year-old male with aneurysmal subarachnoid hemorrhage developed stress cardiomyopathy mimicking STEMI, highlighting the danger of inappropriate antithrombotic therapy in such misdiagnoses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: